Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT06996405

Effect of Access to Dietary Intervention in a Dialysis Unit

Objective:

The aim of this study is to explore the effect of access to individual dietary counselling by a dietitian in the dialysis unit on biochemical values (phosphorus and potassium), diet, nutritional status, quality of life (QoL) and health literacy (HL).

Hypothesis: Having access to a dietitian can better laboratory values and affect dietary intake, nutritional status, QoL and HL in a positive matter.

Method:

Pilot cluster RCT study in three the dialysis units in Region Zealand. Clustering of people on dialysis the same day to either intervention or control group. The groups is expected to be similar regarding clinical characteristics.

Primary outcome: Change in average p-phosphate Secondary outcomes: Change in average p-potassium, number of phosphate binders, number of potassium binders, HeartDiet-score, Nutritional Status, Adherence to diet (End Stage Renal Disease Adherence Questionnaire), Quality of life (Kidney Disease Quality of Life Short Form) and Health literacy (Health Literacy Questionnaire)

Intervention:

The intervention group receives an initial individual dietary interview, monthly follow-up and weekly access to a dietitian in the dialysis unit for four months. The control group receives usual care with referral to a dietitian when needed.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Holbæk Dialysis Unit, Holbæk, Denmark

Loading trial locations.

About this study

Objective:

The aim of this study is to explore the effect of access to individual dietary counselling by a dietitian in the dialysis unit on biochemical values (phosphorus and potassium), diet, nutritional status, quality of life (QoL) and health literacy (HL).

Research question:

What is the effect of access to dietary treatment in people receiving dialysis treatment on biochemical values (phosphorus and potassium), diet, nutritional status, quality of life and health literacy? Hypothesis: Having access to a dietitian can better laboratory values and affect dietary intake, nutritional status, QoL and HL in a positive matter.

Method:

Pilot cluster RCT study in the dialysis units in Holbæk and Slagelse in Region Zealand, Denmark. Clustering of people on dialysis the same day to either intervention or control group. The groups is expected to be similar regarding clinical characteristics. A pilot project will be conducted in 2024 in the dialysis units in Slagelse and Holbæk.

Data collection:

Both groups:

  • Patient characteristics (at the beginning of project): Age and gender, height, medical diagnosis, socioeconomic data (income, job, education, partner status) and dialysis vintage.
  • Clinical Data (before and after the intervention, and at 6 and 12 month after the intervention period): Biochemical values (phosphate, potassium, urea, albumin, PTH), anthropometric measures (dry weight, actual weight), medication, ultrafiltration, and number of contacts with dietitian.
  • Questionnaires and tests (collected before and after the intervention): Body composition (fat, fat-free mass, water), Nutritional status, Intake (HeartDiet Questionnaire), Quality of Life (KDQOL-SF), Health Literacy (HLQ), and previous dietary treatment.

Primary outcome: Change in average p-phosphate Secondary outcomes: Change in average p-potassium, number of phosphate binders, number of potassium binders, HeartDiet-score, Nutritional Status (nutritional screening), Adherence to diet (End Stage Renal Disease Adherence Questionnaire, ESRD-AQ-score), Quality of life (Kidney Disease Quality of Life Short Form, KDQOL-SF-score) and Health literacy (Health Literacy Questionnaire, HLQ-score)

Intervention:

The intervention group receives an initial individual dietary interview, monthly follow-up and weekly access to a dietitian in the dialysis unit for four months.

The individualized dietary treatment based on the patient's preferences and needs according to the Nutrition Care Process. It is carried out according to the practical guidelines from the Danish Dietetic Association on dietary treatment of chronic kidney disease. The dietary treatment uses a dialogic and person-centered approach The intervention is described in the protocol using the TIDieR framework. The control group receives usual care with referral to a dietitian when needed.

Statistics:

The average phosphorus level and standard deviation after a diet intervention was 1.58 ± 0.32 mmol/l, therefore using 0.32 mmol/l in calculation of sample size. An implementation of guidelines and a systematic review showed a difference in phosphosus levels between intervention and control group of 0.23 and 0.30 mmol/l respectively.

Calculation of sample size using "Sample Size Calculator (clincalc.com)". Using the values mentioned above, a power of 80% and a significance of 5% shows a sample size of 18-30 people in each group to show a significant change in phosphorus levels.

Comparison of changes in average values using unpaired t-test, including endpoints of p-phosphorous and p-potassium, QoL-score and health literacy score. For dichotomous endpoints such as nutritional score, comparison of the percentage of the groups within and without specific limits. Data analysis with intention-to-treat and statistical calculations by a person not familiar with the groups.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Able to understand Danish
  • Chronic dialysis treatment (min. 3 month)

Exclusion criteria

  • Dementia
  • Not able to sign a consent form
  • Expected short duration of life, eg. terminal cancer

Treatment and study plan

Access to dietary treatment

Other

Dietary treatment using current nutrition guidelines, dialogic communication and Nutrition Care Process repeatedly by weekly access to a dietitian for four month.

Primary outcomes

  1. Average phosphate

    Time frame: At baseline and after 5 month at the end of the intervention period (last phosphate value before termination of intervention), and 6 and 12 month post-intervention (counting from last day of intervention)

    Difference in average phosphate-level between groups

Secondary outcomes

  1. Phosphate-level

    Time frame: At baseline and after 5 month at the end of the intervention period (last phosphate value before termination of intervention), and 6 and 12 month post-intervention (counting from last day of intervention)

    Number of patients with phosphate-level within range

  2. Phosphate-level

    Time frame: At baseline and after 5 month at the end of the intervention period (last phosphate value before termination of intervention), and 6 and 12 month post-intervention (counting from last day of intervention)

    Number of patients experiencing a increase or decrease in phosphate to/ from range

  3. Phosphate binders

    Time frame: At baseline, changes within the intervention period, after 5 month at the end of the intervention period, and 6 and 12 month after the last day of the intervention

    Change in numbers of prescribed phosphate binders

  4. Average potassium

    Time frame: At baseline and after 5 month at the end of the intervention period (last potassium value before termination of intervention), and 6 and 12 month post-intervention (counting from last day of intervention)

    Difference in average potassium-level between groups

  5. Potassium-level

    Time frame: At baseline and after 5 month at the end of the intervention period (last potassium value before termination of intervention), and 6 and 12 month post-intervention (counting from last day of intervention)

    Number of patients with potassium-level within range

  6. Potassium-level

    Time frame: At baseline and after 5 month at the end of the intervention period (last potassium value before termination of intervention), and 6 and 12 month post-intervention (counting from last day of intervention)

    Number of patients experiencing a increase or decrease in potassium to/ from range

  7. Potassium binders

    Time frame: At baseline, changes within the intervention period, after 5 month at the end of the intervention period, and 6 and 12 month after the last day of the intervention

    Change in numbers of prescribed potassium binders

  8. Nutritional Status

    Time frame: At baseline and after 5 month at the end of the intervention period

    Nutritional screening according to Nutritional Risk Screening (NRS-2002)

  9. Nutritional intake

    Time frame: At baseline and after 5 month at the end of the intervention period

    Nutritional intake collected using the food frequency questionnaire HeartDiet

  10. Quality of Life-score

    Time frame: At baseline and after 5 month at the end of the intervention period

    Quality of Life-score using the questionnaire Kidney Disease Quality of Life Short Form (KDQOL-SF)

  11. Adherence-score

    Time frame: At baseline and after 5 month at the end of the intervention period

    Adherence-score using the questionnaire End Stage Renal Disease Adherence Questionnaire (ESRD-AQ)

  12. Symptom-score

    Time frame: At baseline and after 5 month at the end of the intervention period

    Symptom-score using the questionnaire The Integrated Palliative Outcome Scale - Renal (IPOS-RENAL)

  13. Health Literacy Questionnaire-score

    Time frame: At baseline and after 5 month at the end of the intervention period

    Health Literacy Questionnaire-score using the questionnaire Health Literacy Questionnaire (HLQ)

Sponsors and collaborators

Lead sponsor

Zealand University Hospital

Other

Collaborators

  • Steno Diabetes Center Sjaelland
  • The Danish Dietetic Association
  • The Danish Kidney Association
  • VIA University College

Registry information

Official study title

EFFECT Diet - Cluster RCT and Qualitative Inquiry

Acronym: EFFECTdiet

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
May 30, 2025
Registry last updated
May 30, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.